Liver Cancer Treatment Team
1
Liver Cancer Treatment Team Treatment Features • The control rate for the liver cancer tumors less than 3cm is 90-95% • The control rate of 5-10cm is 85% • The control rate of larger than 10cm is 45% Introduction Main Team Members In 2005, the liver cancer team was established. In the past decade, the number of cases received was about 9,000. Through multi-disciplinary team meetings, the guidelines for treatment and care were developed, the quality of medical treatment and the analysis of treatment survival were monitored, and the adequate and comprehensive treatment plan for liver cancer patients was provided. Convener: Yu-Fan Cheng, MD Deputy Convener: Chih-Che Lin, MD, Jing-Houng Wang, MD Main Team Members: Chao-Long Chen, MD, Chih-Chi Wang, MD, Tsung-Hui Hu, MD, Yen- Yang Chen, MD, Hock-Liew Eng, MD, Hsuan-Chih Hsu, MD… etc. Minimally invasive surgery Precisely resect lesions, reduce the amount of surgical bleeding, and shorten the number of in-patient days Precise Radiofrequency Ablation Treatment (Precision RFA) • 5 years’ survival rate of ablation treatment > 55% • Cancer detection rate for contrast-enhanced ultrasound (CEUS) tumor detection rate is as high as 93-100% • Detection rate for tumor less than 2cm for real‐time virtual sonography (RVS) with navigation and position is 50% Transarterial embolization (Drug-eluting bead & Y90 SIRT) • DEB TACE: There are 415 cases between 2012 and 2018, with a successful rate of 76.6%. The 3-year survival rate of I/II/III stage is 81.5%/61.3%/48.5% respectively. • Y90 SIRT: The 1-year survival rate of liver cancer I/II/III stage is 100%/100%/50%, respectively. Proton Therapy Liver transplant & tumor resection One of the highest survival rates in the world, including liver cancer survival rate • Systemic treatment: Chemotherapy, targeted, and immunotherapy • Provide multiple treatment options for patients with end- stage liver cancer Systemic treatment Coagulation: Professor Chao-Long Chen won the 2019 Lifetime Achievement Award from the International Liver Transplantation Society Chairperson Wen-Jin Cherng of Chang Gung Decision Committee
Transcript of Liver Cancer Treatment Team
Liver Cancer Treatment Team
Treatment Features
• The control rate for the liver cancer tumors less
than 3cm is 90-95%
• The control rate of 5-10cm is 85%
• The control rate of larger than 10cm is 45%
Introduction
Main Team Members
In 2005, the liver cancer team was established. In the past decade, the number of cases received was about 9,000.
Through multi-disciplinary team meetings, the guidelines for treatment and care were developed, the quality of
medical treatment and the analysis of treatment survival were monitored, and the adequate and comprehensive
treatment plan for liver cancer patients was provided.
Convener: Yu-Fan Cheng, MD
Deputy Convener: Chih-Che Lin, MD, Jing-Houng Wang, MD
Main Team Members: Chao-Long Chen, MD, Chih-Chi Wang, MD, Tsung-Hui Hu, MD, Yen-
Yang Chen, MD, Hock-Liew Eng, MD, Hsuan-Chih Hsu, MD… etc.
Minimally invasive surgery
Precisely resect lesions, reduce the amount of surgical
bleeding, and shorten the number of in-patient days
Precise Radiofrequency Ablation
Treatment (Precision RFA)
• 5 years’ survival rate of ablation treatment > 55%
• Cancer detection rate for contrast-enhanced ultrasound
(CEUS) tumor detection rate is as high as 93-100%
• Detection rate for tumor less than 2cm for real‐time virtual
sonography (RVS) with navigation and position is 50%
Transarterial embolization (Drug-eluting
bead & Y90 SIRT)
• DEB TACE: There are 415 cases between 2012 and 2018,
with a successful rate of 76.6%. The 3-year survival rate of
I/II/III stage is 81.5%/61.3%/48.5% respectively.
• Y90 SIRT: The 1-year survival rate of liver cancer
I/II/III stage is 100%/100%/50%, respectively.
Proton Therapy
Liver transplant & tumor resection
One of the highest survival rates in the world,
including liver cancer survival rate
• Systemic treatment: Chemotherapy, targeted, and
immunotherapy
• Provide multiple treatment options for patients with end-
stage liver cancer
Systemic treatment
Coagulation: Professor Chao-Long Chen won
the 2019 Lifetime Achievement Award from
the International Liver Transplantation
Society
Chairperson Wen-Jin
Cherng of Chang Gung
Decision Committee
